Kuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to Contact Law Firm
Kuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to Contact Law Firm
PR Newswire
NEW YORK, Feb. 16, 2024
NEW YORK, Feb. 16, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Kinnate Biopharma Inc. (Nasdaq: KNTE) click to participate
Kinnate Biopharma has agreed to be acquired by XOMA Corporation. According to the agreement, shareholders of Kinnate will receive $2.3352 per share in cash plus an additional at least $0.2527 per share in cash at the closing of the merger plus a non-transferable CVR.
- Diamondback Energy, Inc. (Nasdaq: FANG) click to participate
Diamondback Energy has agreed to merge with Endeavor Energy Resources. Upon completion of the proposed transaction, current Diamondback Energy shareholders are expected to hold 60.5% of the combined entity.
- Haynes International, Inc. (Nasdaq: HAYN) click to participate
Haynes has agreed to be purchased by North American Stainless. According to the agreement, shareholders of Haynes will be paid $61.00 for each share in cash.
- Fresh Vine Wine Inc. (NYSE: VINE) click to participate
Fresh Vine Wine has agreed to merge with Notes Live. The merger is an all-stock transaction, which values Fresh Vine Wine at $18 million.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
SOURCE Kuehn Law, PLLC
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth